Vaccine

In a significant move to combat meningococcal disease, the US Food and Drug Administration (FDA) has approved GSK’s combination vaccine, Penmenvy, for individuals aged 10 to 25 years. This vaccine offers protection against meningococcal infections, a serious bacterial illness caused by Neisseria meningitidis. These infections can lead to severe complications, including life-threatening bloodstream infections and swelling of the brain and spinal cord (meningitis), often resulting in … Read more